Boston Scientific Corporation (LON:0HOY)
97.85
+0.27 (0.28%)
At close: Dec 5, 2025
Boston Scientific Revenue
Boston Scientific had revenue of $5.07B USD in the quarter ending September 30, 2025, with 20.34% growth. This brings the company's revenue in the last twelve months to $19.35B, up 21.61% year-over-year. In the year 2024, Boston Scientific had annual revenue of $16.75B with 17.61% growth.
Revenue (ttm)
$19.35B
Revenue Growth
+21.61%
P/S Ratio
7.54
Revenue / Employee
$365.08K
Employees
53,000
Market Cap
108.51B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 16.75B | 2.51B | 17.61% |
| Dec 31, 2023 | 14.24B | 1.56B | 12.29% |
| Dec 31, 2022 | 12.68B | 794.00M | 6.68% |
| Dec 31, 2021 | 11.89B | 1.98B | 19.92% |
| Dec 31, 2020 | 9.91B | -822.00M | -7.66% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.24B |
| GSK plc | 32.17B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Convatec Group | 1.72B |
| Hikma Pharmaceuticals | 2.35B |
| HUTCHMED (China) | 439.54M |
| Genus | 672.80M |
Boston Scientific News
- 3 days ago - Boston Scientific Corporation (BSX) Presents at Citi Annual Global Healthcare Conference 2025 Prepared Remarks Transcript - Seeking Alpha
- 3 days ago - If You Invested $1000 In Boston Scientific Stock 5 Years Ago, You Would Have This Much Today - Benzinga
- 3 days ago - M&A Strategy Strengthens Boston Scientific's Growth Prospects - Nasdaq
- 7 days ago - Brianne Gardner's Top Picks: Constellation Energy, Microsoft & Boston Scientific - BNN Bloomberg
- 7 days ago - Why Boston Scientific (BSX) is a Top Momentum Stock for the Long-Term - Nasdaq
- 7 days ago - Is Boston Scientific (BSX) a Buy as Wall Street Analysts Look Optimistic? - Nasdaq
- 10 days ago - Boston Scientific's Margins Strengthen in Q3: What's Driving It? - Nasdaq
- 11 days ago - BSX vs. EW: Which Heart Device Stock Is the Smarter Investment Now? - Nasdaq